【摘要】：目的 :通過對胃腸道腫瘤術后輔助化療病人進行營養(yǎng)風險篩查,調查營養(yǎng)不良的發(fā)生率并進行原因分析,為該類病人臨床營養(yǎng)干預治療提供依據(jù)。方法 :自2016年7月至12月對入住普通外科胃腸腫瘤術后并行輔助化療的181例病人,運用PG-SGA進行營養(yǎng)風險篩查,同時檢測血清白蛋白、血紅蛋白和白細胞,記錄病人化療期間的不良反應。根據(jù)性別、年齡、不同腫瘤部位、化療療程、癥狀等進行不同分值的亞組分析。結果 :所有181例病人均完成營養(yǎng)風險篩查,其中PG-SGA得分在0~3分的69例(占38.1%),4~8分即中度營養(yǎng)不良的71例(占39.2%);大于8分即存在嚴重營養(yǎng)不良的41例(占22.7%),4分以上即存在營養(yǎng)不良的共112例占61.9%。對112例營養(yǎng)不良病人進一步分析:胃癌病人PG-SGA得分明顯高于直腸癌病人(P0.05)和結腸癌病人(P0.01);男性發(fā)生率高于女性(P0.05);年齡大于65歲的營養(yǎng)不良發(fā)生率高于65歲以下病人(P0.01)。PG-SGA得分越高化療藥物引起的惡心、嘔吐等毒副反應越重,血紅蛋白、白細胞水平也越低(P0.01)。營養(yǎng)不良與病人化療療程無統(tǒng)計學差異。結論 :胃腸道腫瘤術后輔助化療病人營養(yǎng)不良發(fā)生率高,腫瘤部位、性別、年齡和化療不良反應等是高危因素。
[Abstract]:Objective: to investigate the incidence of malnutrition and analyze the causes of nutritional risk in patients with gastrointestinal tumor after adjuvant chemotherapy, so as to provide evidence for clinical nutritional intervention. Methods: from July to December 2016, 181 patients admitted to general surgery and gastrointestinal tumors treated with adjuvant chemotherapy were screened for nutritional risk by PG-SGA, and serum albumin, hemoglobin and white blood cells were detected at the same time. The adverse reactions during chemotherapy were recorded. According to sex, age, different tumor location, chemotherapy course, symptom and so on, the subgroup analysis of different score was carried out. Results: all 181 patients completed nutritional risk screening, including 69 cases (38.1%) with PG-SGA score of 0 鈮，

本文編號：2487320